430 related articles for article (PubMed ID: 10069646)
41. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
[TBL] [Abstract][Full Text] [Related]
42. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
[TBL] [Abstract][Full Text] [Related]
43. Folic acid treatment of hyperhomocysteinemia in dialysis patients.
Janssen MJ; van Guldener C; de Jong GM; van den Berg M; Stehouwer CD; Donker AJ
Miner Electrolyte Metab; 1996; 22(1-3):110-4. PubMed ID: 8676799
[TBL] [Abstract][Full Text] [Related]
44. Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis.
Tamadon MR; Jamshidi L; Soliemani A; Ghorbani R; Malek F; Malek M
Iran J Kidney Dis; 2011 Mar; 5(2):93-6. PubMed ID: 21368386
[TBL] [Abstract][Full Text] [Related]
45. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
[TBL] [Abstract][Full Text] [Related]
46. Study of the homocysteine status in children with chronic renal failure.
Farid FA; Faheem MS; Heshmat NM; Shaheen KY; Saad SS
Am J Nephrol; 2004; 24(3):289-95. PubMed ID: 15087588
[TBL] [Abstract][Full Text] [Related]
47. What is the meaning of homocysteine in patients on dialysis?
Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
[TBL] [Abstract][Full Text] [Related]
48. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women.
Dierkes J; Kroesen M; Pietrzik K
Int J Vitam Nutr Res; 1998; 68(2):98-103. PubMed ID: 9565824
[TBL] [Abstract][Full Text] [Related]
49. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
Morgan SL; Baggott JE; Lee JY; Alarcón GS
J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
[TBL] [Abstract][Full Text] [Related]
50. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure.
Chauveau P; Chadefaux B; Coudé M; Aupetit J; Kamoun P; Jungers P
Miner Electrolyte Metab; 1996; 22(1-3):106-9. PubMed ID: 8676798
[TBL] [Abstract][Full Text] [Related]
51. Withdrawal of folic acid supplementation in maintenance hemodialysis patients.
Janssen MJ; van den Berg M; van Guldener C; Boers GH; Stehouwer CD
Clin Nephrol; 1994 Aug; 42(2):136-7. PubMed ID: 7955576
[No Abstract] [Full Text] [Related]
52. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
[TBL] [Abstract][Full Text] [Related]
54. Observational study on markers of cardiovascular risk in renal patient: conventional hemodialysis vs. haemofiltration online.
Melero-Rubio E; Párraga-Díaz M; Gómez-Sánchez MP; Pellicer-Villaescusa S; Merchán-Mayado E
J Ren Care; 2009 Dec; 35(4):201-4. PubMed ID: 19909413
[TBL] [Abstract][Full Text] [Related]
55. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
56. Effect of incremental doses of folate on homocysteine and metabolically related vitamin concentrations in nondiabetic patients on peritoneal dialysis.
de Vecchi AF; Novembrino C; Patrosso MC; Cresseri D; Ippolito S; Rosina M; Colucci P; Lando G; Bamonti Catena F
ASAIO J; 2003; 49(6):655-9. PubMed ID: 14655730
[TBL] [Abstract][Full Text] [Related]
57. [Vitamin B12 and folic acid in chronic kidney failure and after kidney transplantation].
Mydlík M; Machánová I; Derzsiová K; Pribylincová V; Reznícek J
Cas Lek Cesk; 1991 Jan; 130(3):84-7. PubMed ID: 2004394
[TBL] [Abstract][Full Text] [Related]
58. Homocysteinemia and vascular disease in end-stage renal disease.
Dennis VW; Robinson K
Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
[TBL] [Abstract][Full Text] [Related]
59. Hyperhomocysteinaemia and end stage renal disease.
Gupta A; Robinson K
J Nephrol; 1997; 10(2):77-84. PubMed ID: 9238614
[TBL] [Abstract][Full Text] [Related]
60. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
